Development and therapeutic implications of small molecular inhibitors that target calcium-related channels in tumor treatment
- 24 April 2024
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 29 (6) , 103995
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 133 references indexed in Scilit:
- ANO1‐Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer‐Associated FibroblastsAdvanced Science, 2023
- Clemizole hydrochloride, a potent TRPC5 calcium channel inhibitor, prevents cisplatin‐induced nephrotoxicity in Spraque–Dawley ratsJournal of Biochemical and Molecular Toxicology, 2023
- Curcumin and NCLX inhibitors share anti-tumoral mechanisms in microsatellite-instability-driven colorectal cancerCellular and Molecular Life Sciences, 2022
- Orai1α, but not Orai1β, co-localizes with TRPC1 and is required for its plasma membrane location and activation in HeLa cellsCellular and Molecular Life Sciences, 2022
- TRP channel expression correlates with the epithelial–mesenchymal transition and high-risk endometrial carcinomaCellular and Molecular Life Sciences, 2021
- Store operated calcium channels in cancer progression2021
- Benzophenanthridine alkaloids suppress lung adenocarcinoma by blocking TMEM16A Ca2+-activated Cl− channelsPflügers Archiv - European Journal of Physiology, 2020
- The potassium channel KCa3.1 promotes cell proliferation by activating SKP2 and metastasis through the EMT pathway in hepatocellular carcinomaInternational Journal of Cancer, 2019
- Matrine is a novel inhibitor of the TMEM16A chloride channel with antilung adenocarcinoma effectsJournal of Cellular Physiology, 2018
- The distinct role of STIM1 and STIM2 in the regulation of store‐operated Ca2+ entry and cellular functionJournal of Cellular Physiology, 2018